208 related articles for article (PubMed ID: 30342273)
21. Olfactory bulb surroundings can help to distinguish Parkinson's disease from non-parkinsonian olfactory dysfunction.
Tremblay C; Mei J; Frasnelli J
Neuroimage Clin; 2020; 28():102457. PubMed ID: 33068873
[TBL] [Abstract][Full Text] [Related]
22. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
23. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
24. The anterior olfactory nucleus in Parkinson's disease.
Pearce RK; Hawkes CH; Daniel SE
Mov Disord; 1995 May; 10(3):283-7. PubMed ID: 7651444
[TBL] [Abstract][Full Text] [Related]
25. The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis.
Rahayel S; Frasnelli J; Joubert S
Behav Brain Res; 2012 May; 231(1):60-74. PubMed ID: 22414849
[TBL] [Abstract][Full Text] [Related]
26. Network-Driven Proteogenomics Unveils an Aging-Related Imbalance in the Olfactory IκBα-NFκB p65 Complex Functionality in Tg2576 Alzheimer's Disease Mouse Model.
Palomino-Alonso M; Lachén-Montes M; González-Morales A; Ausín K; Pérez-Mediavilla A; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077059
[TBL] [Abstract][Full Text] [Related]
27. α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
Brain Struct Funct; 2014 Sep; 219(5):1513-26. PubMed ID: 24135772
[TBL] [Abstract][Full Text] [Related]
28. Metal concentrations and distributions in the human olfactory bulb in Parkinson's disease.
Gardner B; Dieriks BV; Cameron S; Mendis LHS; Turner C; Faull RLM; Curtis MA
Sci Rep; 2017 Sep; 7(1):10454. PubMed ID: 28874699
[TBL] [Abstract][Full Text] [Related]
29. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
30. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer's/Parkinson's diseases.
Mahin A; Soman SP; Modi PK; Raju R; Keshava Prasad TS; Abhinand CS
J Neurovirol; 2024 Feb; 30(1):57-70. PubMed ID: 38167982
[TBL] [Abstract][Full Text] [Related]
32. Treatment with AC pulsed electromagnetic fields improves olfactory function in Parkinson's disease.
Sandyk R
Int J Neurosci; 1999 Apr; 97(3-4):225-33. PubMed ID: 10372649
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
Muntané G; Dalfó E; Martinez A; Ferrer I
Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
[TBL] [Abstract][Full Text] [Related]
34. Olfactory dysfunction in Parkinson's disease.
Wszolek ZK; Markopoulou K
Clin Neurosci; 1998; 5(2):94-101. PubMed ID: 10785834
[TBL] [Abstract][Full Text] [Related]
35. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
[TBL] [Abstract][Full Text] [Related]
36. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
Huisman E; Uylings HB; Hoogland PV
Mov Disord; 2004 Jun; 19(6):687-92. PubMed ID: 15197709
[TBL] [Abstract][Full Text] [Related]
37. Mitral cells and the glucagon-like peptide 1 receptor: The sweet smell of success?
Bagnoli E; FitzGerald U
Eur J Neurosci; 2019 Feb; 49(4):422-439. PubMed ID: 30120857
[TBL] [Abstract][Full Text] [Related]
38. Olfactory function combined with morphology distinguishes Parkinson's disease.
Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y
Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741
[TBL] [Abstract][Full Text] [Related]
39. Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein.
Macknin JB; Higuchi M; Lee VM; Trojanowski JQ; Doty RL
Brain Res; 2004 Mar; 1000(1-2):174-8. PubMed ID: 15053964
[TBL] [Abstract][Full Text] [Related]
40. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
Norès JM; Biacabe B; Bonfils P
Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
